WEST BEND, Wis., April 11, 2011 /PRNewswire/ -- Leading-edge Clinical Pharmacology and Cardiac Core Lab provider, Spaulding Clinical Research, LLC proudly announces the addition of Aziz Karim, BPharm, PhD, FCP, ABCP to their team as a consultant and advisor to Spaulding's Clinical Pharmacology/Pharmacokinetic department.
Dr. Karim's expertise lies in the principles of Clinical Pharmacology and rational drug development including the design of drug-drug interaction and bioavailability/bioequivalence studies. With over 30 years of experience in Pharmaceutical Sciences and Clinical Pharmacology, he has contributed to the development and marketing approvals of over 30 NCEs and/or Novel Drug Delivery Systems and has interfaced extensively with global regulatory bodies. Most recently, Dr. Karim was the Vice President of Global Clinical Pharmacology at Takeda Pharmaceuticals. Prior to Takeda, he held the role of Distinguished Scientist & Senior Director of Clinical Pharmacology for G.D. Searle & Co. and Pharmacia.
Daniel Selness, General Manager and Senior Vice President of Operations, commented, "Aziz's understanding of early clinical development, ability to design appropriate pharmacology trials/programs, and analysis expertise are wonderful complements to our existing services. Pharmacokinetic design and analysis is an imperative part of NCE development and if not approached correctly, may result in significant delays to programs. Keeping with our company goals, his experience will continue to improve clinical trials, ultimately leading to safer drugs in the marketplace."
CEO Randol Spaulding stated, "The addition of Aziz's experience and skills furthers our ability to be a 'one-stop-shop' for pharmaceutical companies throughout the world. We continue to focus on being the innovation leader in the industry."
To learn more about how Spaulding can assist with your Clinical Pharmacology programs or Pharmacokinetic analysis, please contact us at SpauldingPK@spauldingclinical.com or 262-306-3331. Spaulding Clinical will be demonstrating their cutting edge "Spaulding IQ" ECG device and Protocol from June 19 22, 2011 in booth 1905 at the DIA meeting in Chicago, Illinois.
About Spaulding Clinical
Spaulding Clinical Research, LLC (www.spauldingclinical.com) is a Clinical Pharmacology Research Unit and Cardiac Core Lab that offers a full range of global services from study design through study execution/conduct, data management, statistical analysis, and clinical summary/expert reporting. Spaulding has extensive experience conducting TQT, first-in-human, multiple rising dose, bioavailability/bioequivalence, drug interaction, and food effect studies. As a Phase 1-4 Core Lab provider, Spaulding offers the complete suite of equipment provisioning and electrocardiogram over-reading services with state-of-the-art technologies and expertly trained cardiologists.
SOURCE Spaulding Clinical Research, LLC